a genetic medicines company, which focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options
Industry Biotechnology
A.I.dvisor tells us that PASG and CMPX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PASG and CMPX's prices will move in lockstep.
Ticker / NAME | Correlation To PASG | 1D Price Change % | ||
---|---|---|---|---|
PASG | 100% | -12.87% | ||
CMPX - PASG | 33% Poorly correlated | -5.59% | ||
ALEC - PASG | 29% Poorly correlated | -7.66% | ||
NKTX - PASG | 28% Poorly correlated | -4.59% | ||
PRME - PASG | 28% Poorly correlated | -8.33% | ||
ATAI - PASG | 27% Poorly correlated | -7.53% | ||
More |